Evaluation and Treatment of Chemotherapy Extravasation Injuries

Ali Reza Farid Khomami

Mahak children"s hospital

Extravasation of chemotherapic vesicant agents can result in significant tissue damage , alteration in limb function , and pain

cytotoxic chemotherapy can cause local reactions with varying degrees of severity following extravasation. Quality of life for long-term survivors can be severely impacted by negative sequelae from vesicant extravasation

Today , intravenous cannulation and administration of cytotoxic chemotherapy are frequently performed by nurses. therafore , measures which promote the prevention of extravasation are explored in this paper and suggestions for clinical practice are made. Currently , there is no known prevention therapy. early detection and intervention are paramount to halt tissue damage and reduce the chance of permanent disability or disfiguration

vesicant , irritant and flare reaction are defined , and managment options for each are debated

This workshop provides an overwiew of known chemotherapeutic vesicants mechlorethamine , mitomycin , doxorobicin , vincristine  and vinblastine , site , vascular access devices and centeral venous lines , curent treatment strategies , and investigational therapies. This workshop also is  a review of the last finding about risk factors , classification of complication of chemotherapy drug leakage , assessment and treatment of extravasation , nursing care , documentation and legal consideration , education and home care patients

A brief discussion of the legal implications of extravasation injuries and recommended key points for medical record documentation are included. finally , in the light of experience and available evidence , a new uncomplication managment protocol is proposed

 خواننده گرامی سلام ؛ 

با تواضع و ادب ...سایت "ایران انکو" پیرامون موضوعات سرطان به قلم نگارنده  افتتاح شد .

بازدید ، نظرات و نوشته های شما دلگرمی بخش خواهد بود.